Reactive oxygen species, antioxidant status and fibromyalgia

Journal of Musculoskeletal Pain

Volumn 5, Issue 4, 1997, Pages 5-15

  Eisinger, J ^a,b   Gandolfo, C ^a   Zakarian, H ^a   Ayavou, T ^a  

^a Centre Hospitalier Intercommunal Toulon La Seyne sur Mer   (France)

^b Centre de Gerontologie Georges CLEMENCEAU   (France)

Author keywords

Fibromyalgia; Nitric oxide; Paracetamol; Protein carbonyls; Thiols

Indexed keywords

ANTIOXIDANT; MALONALDEHYDE; NITRIC OXIDE; PARACETAMOL; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; FIBROMYALGIA; HUMAN; HUMAN CELL; LIPID PEROXIDATION; PATHOPHYSIOLOGY;

EID: 0030702131     PISSN: 10582452     EISSN: None     Source Type: Journal    
DOI: 10.1300/J094v05n04_02     Document Type: Article

References (54)

1. Sen CK: Oxidants and antioxidants in exercise. J Appl Physiol 79: 675-686; 1995.
2. Tian L, Cai Q, Bowen R, Wei H: Effect of caloric restriction on age related oxidative modifications of macromolecules and lymphocyte in rats. Free Radic Biol Med 19:859-865; 1995.
3. Gandolfo G, Marie PA, Brue F, Chouviat A, Ayavou T: Exercice physique et radicaux libres [Exercise and free radicals]. Lyon Mediterranée Medical 32: 2185-2189; 1996.
4. Bennett RM: The origin of myopain: an integrated hypothesis of focal muscle changes and sleep disturbance in patients with fibromyalgia syndrome. J Musculoske Pain 1(3/4): 95-112; 1993.
5. Zhao X, Yan S, Zhai FL, Tïan CM, Song LX: Oxygen free radicals may be involved in the pathogenesis of fibromyalgia. J Musculoske Pain, 3; Suppl # 1: 111; 1995. Abstract.
6. Eisinger J, Plantamura A, Marie PA, Ayavou T: Selenium and magnesium status in fibromyalgia. Magnes Res 7: 285-8; 1994.
7. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechlner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbraun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russel U, Sheon RP: The American College of Rheumatology 1990 criteria for a classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33: 160-173; 1990.
8. Günther T, Höllriegl V: Increase protein oxidation by magnesium deficiency and vitamin E depletion. Magnesium Bulletin 16; 3: 101-103; 1994.
9. Ayavou T, Marie PA, Pouly E, Zakarian H, Eisinger J: Oxyde nitrique et fibromyalgie [Nitric oxide and fibromyalgia]. Lyon Mediterranée Medical, 32: 2194-2196; 1996.
10. Beutler E: Red Cell Metabolism and Manual of Biochemical Methods. 2nd ed. Grune and Stratton New York: 1975.
11. McCrae F, Reglinski J, Smith WE, Brzeaski M, Sturrock RD: The action of membrane bound sulphydryl groups. Clin Chim Acta 195: 41-46; 1990.
12. Allen KGC, Arthur JD: Inhibition by 5-sulphosalycilic acid of the glutathione reductase recycling assay for glutathione analyse. Clin Chim Acta 162: 237-239; 1987.
13. Sun Y, Oberley LW, Li Y: Simple method for clinical assay of SOD CuZn. Clin Chem 34: 497-500; 1988.
14. Kötter I, Dürk H, Schweinsberg F, Saal JG: Selenium (SE) levels in fibromyalgia (FM). J Musculoske Pain 3; Suppl # 1:46; 1995.
15. Romano TJ, Stiller JW: Magnesium deficiency in fibromyalgia syndrome. Journal of Nutritional Medicine 4: 165-7; 1994.
16. Romano TJ: Vitamin A levels in patients with soft tissue rheumatism syndromes. J Musculoske Pain 3; Suppl # 1: 107; 1995.
17. Eisinger J, Plantamura A, Ayavou T: Glycolysis abnormalities in fibromyalgia. J Amer Coll Nutr 13: 144-148; 1994.
18. Yunus MB, Aldag JC, Dailey JW, Jobe PC: Interrelationships of biochemical parameters in classification of fibromyalgia syndrome and healthy normal controls. J Musculoske Pain 3; Suppl # 1: 15-24; 1995.
19. Bennett RM, Clark SR, Burckhardt CS, Cook D: IGF-1 assays and other GH tests in 500 fibromyalgia patients. J Musculoske Pain 3; Suppl # 1: 109; 1995.
20. Hussain MA, Schmidtz O, Mengel A, Keller A, Christiansen JS, Zapf J, Frosch ER: Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation and enhances insulin sensitivity in humans. J Clin Invest 92: 2249-2256; 1993.
21. Jubrias SA, Bennett RM, Klug GA: Increased incidence of a resonance in the phosphodiester region of 31-P nuclear magnetic resonance spectra in the skeletal muscle of fibromyalgia patients. Arthritis Rheum 37: 801-807; 1994.
22. Eisinger J, Dupond JL, Cozzone PJ: Anomalies de la glycolyse au cours des fibromyalgies: Etude biologique et thérapeutique [Glycolysis abnormalities: a biological and therapeutic study]. Lyon Mediterranée Medical 32: 2180-2181; 1996.
23. Bennett RM: The contribution of muscle to the generation of fibroinyalgia symptomatology. J Musculoske Pain 4 (1/2): 35-59; 1996.
24. Rayssiguier Y, Durlach J, Gueux E, Rock E, Mazur A: Magnesium and ageing. I. Experimental data: importance of oxidative damage. Magnes Res 6: 369-378; 1993.
25. Flanagan RJ: The role of acetylcysteine in clinical toxicology. Medical Toxicology 2: 93-104; 1987.
26. Lucesoli F, Fraga CG: Oxidative damage to lipids and DNA concurrent with decrease of antioxidants in rat testes after acute iron intoxication. Arch Biochem Biophys 316: 567-71; 1995.
27. Oteiza PI, Olin KL, Fraga CG, Keen CL: Zinc deficiency causes oxidative damage to proteins, lipids and DNA in rat testes. J Nutr 125: 823-829; 1995.
28. Saxton JM, Donnelly AE, Roper HP: Indices of free radical mediated damage following maximum voluntary eccentric and concentric muscular work. Eur J Appl Physiol 68: 189-93; 1994.
29. Yan IJ, Traber MG, Kobuchi H, Matsugo SM, Tritschler HJ, Packer L: Efficacy of hypochlorous acid scavengers in the prevention of protein carbonyl formation. Arch Biochem Biophys 327: 330-34; 1996.
30. O'Neill CA, Hazliwell B, Van Der Vliet A, Davis PA, Packer L, Tritschler H, Strohman WJ, Rieland T, Cross CE, Reznick AZ: Aldehyde-induced protein modifications in human plasma: protection by glutathione and dihydrolipoic acid. J Lab Clin Med 124: 359-70; 1994.
31. de Mondenard JP: Cocarboxylase et acide thioctique en pratique sportive [Cocarboxylase, thioetic acid and performances]. Lyon Méditerranée Médical 28; 861-864; 1992.
32. Jacobsen S, Danneskiold-Samsoe B, Andersen RB: Oral S-Adenosylmethionine in primary fibroinyalgia. Double blind clinical evaluation. Scand J Rheumatol 20: 294-302; 1991.
33. Russell IJ: Neurochemical pathogenesis of fibroinyalgia syndrome. J Musculoske Pain 4 (1/2): 61-92; 1995.
34. Silva MA, Cunha GM, Viana GS, Rao VS: Taurine modulates chemical nociception mice. Braz J Med Biol Res 26: 1319-1324; 1993.
35. Szantay J, Siortea P, Georgoceanu E: Neutralization of activated oxygens in elderly patients through supplementation with high magnesium and thiol group contents. Magnes Res 6: 302; 1993.
36. Abraham GE, Flechas JD: Management of fibroinyalgia: a rationale for the use of magnesium and malic acid. J Nutr Med 3:49-59, 1992.
37. Plioplys AV, Plioplys S: Serum levels of carnitine in chronic fatigue syndrome: clinical correlates. Neuropsychobiology; 32 (3): 132-138; 1995.
38. Koster JF: Free radicals-mediated damage and carnitine esters. The Carnitine System Edited by JW de Jong and R Ferrari. Kluwer Academy Publisher Amsterdam: 123-132; 1995.
39. Rodeberg DA, Chaet MS, Bass RC, Arkovitz MS, Garcia VF: Nitric oxide: an overview. Am J Surg 170: 292-303; 1995.
40. Koller A, Huang A, Sun D, Kaley G: Exercise training augments flow-dependent dilatation in rat skeletal muscle arterioles. Role of endothelial nitric oxide and prostaglandins. Circ Res 76: 544-50; 1995.
41. Kobzik L, Reid MB, Bredt DS, Stamler JS: Nitric oxide in skeletal muscle. Nature 372: 546-548; 1994.
42. Steel JG, Terenghi G, Chung JM, Na HS, Carlton SM, Polak JM: Increased nitric oxide synthase immunoreactivity in rat dorsal root ganglia in a neuropathic pain model. Neurosci Lett 169: 81-84; 1994.
43. Olesen J, Thomson LL, Lassen LH, Olsen IJ: The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia 15: 94-100; 1995.
44. Giovengo SL, Russell U, Larson AA: Amino acids in cerebrospinal fluid (CSF) of patients with fibromyalgia. J Musculoske Pain 3; Suppl # 1:9; 1995.
45. Wu G, Majumdar S, Zhang J, Lee H, Meininger CJ: Insulin stimulates glycolysis and pentose cycle activity in bovine microvascular endothelial cells. Comp Biochem Physiol Pharmacol Toxicol Endocrinol 108: 179-185; 1994.
46. Bjorkman R, Halman KM, Hedner J, Hedner T, Henning M: Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain 57: 259-264; 1994.
47. Kawabata A, Manabe S, Manabe Y, Tagagi H: Effects of topical administration of L-arginine on formaline-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br J Pharmacol 112: 547-550; 1994.
48. Mense S, Hoheisel U, Reinert A: Biochemical pathogenesis of myofascial pain. J Musculoske Pain 3; Suppl # 1: 165; 1995.
49. Kawabata A, Umeda N, Takagi H: L-arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway. Br J Pharmacol 109: 73-79; 1993.
50. Berrazuetta JR, Salas E, Ochetoco A, Poveda JJ, Sanchez de Vega M J: Accion analgesica periferica del donador exogeno de oxido nitrico: nitroglicerina. Estudio controle frente a placebo de la accion de la nitroglicerina transdermica sobre la sensibilidad dolorosa en el antcbrazo. [The peripheral analgesic action of the exogenous nitric oxide donor: nitroglycerin. A placebo-controlled study of the transdermal action of nitroglycerin on pain sensitivity in the forearm.]. Rev Esp Cardiol 46: 10-14; 1993.
51. Clauw DJ, Radulovic D, Katz P, Baraniuk J, Barbey JT: Tilt table testing as a measure of dysautonomia in fibromyalgia. J Musculoske Pain 3; Suppl # 1: 10; 1995.
52. Teitelbaum J: From fatigued to fantastic! Deva Press, Annapolis, 1995, p. 192.
53. Eisinger J, Zakarian H, Plantamura A, Clairet D, Ayavou T: Studies of transketolase in chronic pain. J Adv Med 5: 105-114; 1992.
54. Bode-Boger SM, Boger RH, Schroder EP, Frolich JC: Exercise increases systemic nitric oxide production in men. J Cardiovasc Risk 1: 173-178; 1994.